Comparison of Postoperative GI motility Recovery According to the Types of Neuromuscular blockade reversal agent

Not Applicable

Completed

• Conditions: Diseases of the digestive system

• Registration Number: KCT0004330
• Lead Sponsor: Daegu Fatima Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 5 November 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

American Society of Anesthesiologists (ASA) physical status I or II.

Exclusion Criteria

Patients requiring emergency care due to their inability to control nothing by mouth (NPO) fasting time, and those diagnosed with diabetes, ulcerative colitis, or Crohn’s disease, all of which can affect patients’ GI motility. Patients with renal dysfunction were also excluded

Study & Design

• Study Type: Interventional Study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The data on the time elapsed between the injection of NMB reversal agents and the first gas out and defecation

Secondary Outcome Measures

Name	Time	Method
Any adverse effects (such as nausea, vomiting, and dry mouth), as well as the types of stools